Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Oral Toxoplasmosis; Protozoal infections; Cryptosporidiosis; Susceptible infections
Age: Adult
Dose: Oral – 6-9 million units/day
Frequency: in 2-3 divided doses
Indication: Oral Toxoplasmosis; Protozoal infections; Cryptosporidiosis; Susceptible infections
Age: Adult
Condition: severe infections
Dose: Oral – 15 million units/day
Frequency: given in divided doses

Child Dose

Clinical InformationAdministration Information
Indication: Chemoprophylaxis of congenital toxoplasmosis
Age: Child and Neonates
Dose: Oral – 50 mg/kg
Frequency: twice daily
Administration
  • Can be taken with or without food
  • Complete full course
Side Effect

Drug Interaction

Drug NameRisk Factors
Carbidopa, Levodopa
Decreases carbidopa absorption and levodopa concentrations
Astemizole, Cisapride, Terfenadine
Increased risk of ventricular arrhythmias

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a dry place between 15ºC and 30ºC.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.